No abstract available
MeSH terms
-
AIDS-Related Opportunistic Infections*
-
Anti-Retroviral Agents / therapeutic use
-
HIV Infections* / complications
-
HIV Infections* / drug therapy
-
HIV Infections* / prevention & control
-
Histoplasmosis* / complications
-
Histoplasmosis* / drug therapy
-
Histoplasmosis* / prevention & control
-
Humans
-
Secondary Prevention
Grants and funding
The authors received no specific funding for this work.